Oryzon Genomics SA Capital Reinvestment Ratio
Oryzon Genomics SA capital reinvestment ratio. Oryzon Genomics SA (ORY) has a Capital Reinvestment Ratio of 0.17x as of December 2015, meaning it reinvests 0% of its operating cash flow (€523.10K) in capital expenditures (€87.70K). Check Oryzon Genomics SA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Oryzon Genomics SA (2013–2015)
Capital reinvestment ratio of Oryzon Genomics SA from 2013 to 2015. This chart tracks Oryzon Genomics SA's Capital Reinvestment Ratio across 3 annual periods. Also explore ORY shareholders equity momentum to track the company's year-over-year net asset growth rate.
Oryzon Genomics SA Capital Reinvestment Ratio by Year (2013–2015)
Oryzon Genomics SA capital reinvestment ratio by year from 2013 to 2015. For the full cash flow conversion analysis, see Oryzon Genomics SA cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.17x | €523.14K | €87.65K | ▲ +4222.7% |
| 2014 | 0.00x | €12.13 Million | €47.00K | ▼ -0.6% |
| 2013 | 0.00x | €12.13 Million | €47.30K | — |